Vivani Medical IncNASDAQ:VANI
- LAST PRICE1.9350
- TODAY'S CHANGE (%)-0.0850 (-4.2079%)
- Bid / Lots1.9300/ 16
- Ask / Lots1.9400/ 4
- Open / Previous Close2.0000 / 2.0200
- Day Range
- 52 Week Range
- Volume213,650
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VANI |
|---|---|---|
| 09:32 ET | 2031 | 1.98 |
| 09:41 ET | 100 | 2 |
| 09:43 ET | 800 | 2.005 |
| 09:45 ET | 200 | 2.0008 |
| 09:48 ET | 61643 | 2 |
| 09:56 ET | 17581 | 1.94 |
| 09:57 ET | 5699 | 1.94 |
| 10:01 ET | 794 | 1.94 |
| 10:03 ET | 200 | 1.94 |
| 10:06 ET | 2200 | 1.9422 |
| 10:08 ET | 4400 | 1.9407 |
| 10:10 ET | 7633 | 1.93 |
| 10:14 ET | 1030 | 1.94 |
| 10:15 ET | 1000 | 1.92 |
| 10:17 ET | 500 | 1.928 |
| 10:19 ET | 241 | 1.92 |
| 10:21 ET | 550 | 1.93 |
| 10:44 ET | 850 | 1.92 |
| 10:46 ET | 500 | 1.93 |
| 10:48 ET | 200 | 1.939 |
| 10:51 ET | 100 | 1.92 |
| 10:55 ET | 1100 | 1.92 |
| 10:57 ET | 400 | 1.92 |
| 11:00 ET | 2182 | 1.9293 |
| 11:09 ET | 2566 | 1.92 |
| 11:11 ET | 1566 | 1.92 |
| 11:13 ET | 300 | 1.925 |
| 11:15 ET | 100 | 1.92 |
| 11:20 ET | 1100 | 1.92 |
| 11:22 ET | 100 | 1.92 |
| 11:26 ET | 831 | 1.92 |
| 11:29 ET | 3414 | 1.92 |
| 11:33 ET | 100 | 1.93 |
| 11:36 ET | 6029 | 1.92 |
| 11:44 ET | 513 | 1.92 |
| 11:45 ET | 500 | 1.9299 |
| 11:49 ET | 19260 | 1.91 |
| 11:51 ET | 1500 | 1.91 |
| 11:54 ET | 492 | 1.91 |
| 11:58 ET | 600 | 1.91 |
| 12:09 ET | 333 | 1.902 |
| 12:12 ET | 300 | 1.9191 |
| 12:14 ET | 130 | 1.905 |
| 12:16 ET | 500 | 1.9183 |
| 12:21 ET | 250 | 1.9 |
| 12:27 ET | 200 | 1.92 |
| 12:30 ET | 3795 | 1.91 |
| 12:36 ET | 100 | 1.9097 |
| 12:43 ET | 100 | 1.909 |
| 12:52 ET | 100 | 1.9061 |
| 12:54 ET | 100 | 1.91 |
| 12:59 ET | 500 | 1.9065 |
| 01:01 ET | 500 | 1.905 |
| 01:03 ET | 150 | 1.9009 |
| 01:06 ET | 183 | 1.9093 |
| 01:08 ET | 500 | 1.9065 |
| 01:14 ET | 200 | 1.905 |
| 01:19 ET | 100 | 1.9031 |
| 01:28 ET | 500 | 1.9078 |
| 01:32 ET | 3995 | 1.904 |
| 01:33 ET | 3816 | 1.9 |
| 01:35 ET | 299 | 1.894 |
| 01:37 ET | 7071 | 1.9251 |
| 01:48 ET | 3500 | 1.93 |
| 01:50 ET | 166 | 1.9209 |
| 01:53 ET | 356 | 1.92 |
| 01:55 ET | 3083 | 1.8828 |
| 01:57 ET | 600 | 1.89 |
| 02:00 ET | 200 | 1.9 |
| 02:04 ET | 250 | 1.91 |
| 02:09 ET | 900 | 1.92 |
| 02:11 ET | 1800 | 1.92 |
| 02:13 ET | 2988 | 1.91 |
| 02:15 ET | 478 | 1.92 |
| 02:26 ET | 900 | 1.9307 |
| 02:27 ET | 200 | 1.94 |
| 02:33 ET | 900 | 1.935 |
| 02:36 ET | 100 | 1.935 |
| 02:44 ET | 200 | 1.935 |
| 02:45 ET | 768 | 1.934 |
| 02:56 ET | 100 | 1.935 |
| 03:02 ET | 100 | 1.935 |
| 03:07 ET | 100 | 1.935 |
| 03:14 ET | 100 | 1.935 |
| 03:16 ET | 723 | 1.935 |
| 03:18 ET | 338 | 1.94 |
| 03:20 ET | 100 | 1.935 |
| 03:21 ET | 100 | 1.935 |
| 03:25 ET | 201 | 1.9308 |
| 03:32 ET | 1495 | 1.93 |
| 03:36 ET | 100 | 1.935 |
| 03:39 ET | 100 | 1.935 |
| 03:41 ET | 100 | 1.935 |
| 03:43 ET | 100 | 1.935 |
| 03:45 ET | 100 | 1.935 |
Mar 26, 2024
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results, from 8:30AM ET on Tuesday Mar 26, 2024 by Dow Jones
8:30AM ET on Tuesday Mar 26, 2024 by Dow JonesPress Release: Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results, from 8:30AM ET on Tuesday Mar 26, 2024 by Dow Jones
8:30AM ET on Tuesday Mar 26, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vivani Medical Inc | 111.1M | -3.8x | --- |
Delcath Systems Inc | 123.9M | -1.6x | --- |
Monogram Orthopaedics Inc | 81.2M | -5.6x | --- |
IR-MED Inc | 80.4M | -16.1x | --- |
Asensus Surgical Inc | 74.8M | -0.8x | --- |
KORU Medical Systems Inc | 95.1M | -7.1x | --- |
Company Information
Vivani Medical, Inc. is a preclinical-stage biopharmaceutical company. The Company develops miniaturized and subdermal implants utilizing its NanoPortal technology to enable the delivery of a range of medicines to treat chronic diseases. It is engaged in the development of the Company’s lead programs NPM-115 and NPM-119, is a GLP-1 implant candidates for the treatment of chronic weight management and patients with type 2 diabetes, respectively. Its other pipeline product candidates include NPM-139, and OKV-119. It uses this platform technology to develop and commercialize drug implant candidates for the treatment of chronic disease and medication non-adherence. It operates through two segments: Biopharm Division and Neuromodulation Division. The Company’s implant technology, which it refers as NanoPortal, utilizes a space-efficient design that allows a miniaturized implant to provide many months of therapeutic delivery of potent molecules.
Contact Information
- Headquarters
- 1350 S. LOOP ROADALAMEDA, CA, United States 94502
- Phone
- 818-833-5000
- Fax
- 818-833-5067
Executives
- Non-Executive Independent Chairman of the Board
- Gregg Williams
- Chief Executive Officer, Director
- Adam Mendelsohn
- Chief Financial Officer
- Brigid Makes
- Chief Operating Officer
- Truc Le
- Chief Business Officer
- Donald Dwyer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $111.1M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 55.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 3.21 |
EPS | $-0.50 |
Book Value | $0.41 |
P/E Ratio | -3.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
